NCI扩大了与Medidata的伙伴关系,通过自动化数据传输提高癌症试验效率。 NCI expands partnership with Medidata to boost cancer trial efficiency via automated data transfer.

国家癌症研究所扩大了与Medidata的17年伙伴关系,向选定的主要议定书组织提供获得健康记录连接和健康伴侣服务的机会。 The National Cancer Institute has expanded its 17-year partnership with Medidata, granting select Lead Protocol Organizations access to Health Record Connect and Rave Companion. 这些工具使患者数据从电子健康记录向临床试验平台的传输自动化,减少人工输入,提高准确性,并有可能加快90%的数据输入速度。 These tools automate patient data transfer from electronic health records to clinical trial platforms, cutting manual entry, boosting accuracy, and potentially speeding data input by up to 90%. 整合提高了效率,支持提高数据质量,并使研究地点能够更加注重病人护理。 The integration enhances efficiency, supports better data quality, and allows research sites to focus more on patient care. 此举旨在加速癌症治疗发展, 改善全国癌症研究所广泛的临床研究组合的试验操作。 The move aims to accelerate cancer treatment development and improve trial operations across NCI’s broad clinical research portfolio.